ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Recombinant LIF Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-10F18658
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Human Recombinant LIF Market Research Report 2024
BUY CHAPTERS

Global Human Recombinant LIF Market Research Report 2024

Code: QYRE-Auto-10F18658
Report
November 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lif
Dalian Meilun Biotech Co., Ltd.
STEMCELL
Merck
Yeasen
R&D Systems, Inc.
Thermo Fisher Scientific Inc
Cell Guidance Systems LLC
ProSpec-Tany TechnoGene Ltd
ACROBiosystems
Neuromics
BioLegend
InVitria
BPS Bioscience
ScienCell Research Laboratories, Inc.

Human Recombinant LIF Market Size

The global Human Recombinant LIF market was valued at US$ 341 million in 2023 and is anticipated to reach US$ 534 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.

Human Recombinant LIF Market

Human Recombinant LIF Market

Leukemia inhibitory factor (LIF) is a pleiotropic factor produced by multiple cell types, including T cells, myelomonocytic lineage, fibroblasts, liver, heart, and melanoma. LIF promotes the long-term maintenance of embryonic stem cells by inhibiting spontaneous differentiation.
North American market for Human Recombinant LIF is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Recombinant LIF is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Human Recombinant LIF include STEMCELL, Merck, YEASEN, Dalian Meilun Biotech Co., Ltd., R&D Systems, Inc., Thermo Fisher Scientific Inc., Cell Guidance Systems LLC, Prospec-Tany Technogene Ltd., ACROBiosystems, Neuromics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Recombinant LIF, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Recombinant LIF.
The Human Recombinant LIF market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Human Recombinant LIF market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Recombinant LIF manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Recombinant LIF Market Report

Report Metric Details
Report Name Human Recombinant LIF Market
Accounted market size in 2023 US$ 341 million
Forecasted market size in 2030 US$ 534 million
CAGR 6.5%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Purity < 97%
  • Purity ≥ 97%
Segment by Application
  • Laboratory
  • University
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company STEMCELL, Merck, YEASEN, Dalian Meilun Biotech Co., Ltd., R&D Systems, Inc., Thermo Fisher Scientific Inc., Cell Guidance Systems LLC, Prospec-Tany Technogene Ltd., ACROBiosystems, Neuromics, BioLegend, Inc, InVitria, BPS Bioscience, ScienCell Research Laboratories, Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Recombinant LIF manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Recombinant LIF in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Human Recombinant LIF Market growing?

Ans: The Human Recombinant LIF Market witnessing a CAGR of 6.5% during the forecast period 2024-2030.

What is the Human Recombinant LIF Market size in 2030?

Ans: The Human Recombinant LIF Market size in 2030 will be US$ 534 million.

Who are the main players in the Human Recombinant LIF Market report?

Ans: The main players in the Human Recombinant LIF Market are STEMCELL, Merck, YEASEN, Dalian Meilun Biotech Co., Ltd., R&D Systems, Inc., Thermo Fisher Scientific Inc., Cell Guidance Systems LLC, Prospec-Tany Technogene Ltd., ACROBiosystems, Neuromics, BioLegend, Inc, InVitria, BPS Bioscience, ScienCell Research Laboratories, Inc

What are the Application segmentation covered in the Human Recombinant LIF Market report?

Ans: The Applications covered in the Human Recombinant LIF Market report are Laboratory, University, Others

What are the Type segmentation covered in the Human Recombinant LIF Market report?

Ans: The Types covered in the Human Recombinant LIF Market report are Purity < 97%, Purity ≥ 97%

Recommended Reports

Recombinant Proteins

Cellular Therapies

Leukemia & Factors

1 Human Recombinant LIF Market Overview
1.1 Product Definition
1.2 Human Recombinant LIF by Type
1.2.1 Global Human Recombinant LIF Market Value Comparison by Type (2024-2030)
1.2.2 Purity < 97%
1.2.3 Purity ≥ 97%
1.3 Human Recombinant LIF by Application
1.3.1 Global Human Recombinant LIF Market Value by Application (2024-2030)
1.3.2 Laboratory
1.3.3 University
1.3.4 Others
1.4 Global Human Recombinant LIF Market Size Estimates and Forecasts
1.4.1 Global Human Recombinant LIF Revenue 2019-2030
1.4.2 Global Human Recombinant LIF Sales 2019-2030
1.4.3 Global Human Recombinant LIF Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Recombinant LIF Market Competition by Manufacturers
2.1 Global Human Recombinant LIF Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Recombinant LIF Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Recombinant LIF Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Human Recombinant LIF, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Recombinant LIF, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Recombinant LIF, Product Type & Application
2.7 Global Key Manufacturers of Human Recombinant LIF, Date of Enter into This Industry
2.8 Global Human Recombinant LIF Market Competitive Situation and Trends
2.8.1 Global Human Recombinant LIF Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Recombinant LIF Players Market Share by Revenue
2.8.3 Global Human Recombinant LIF Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Recombinant LIF Market Scenario by Region
3.1 Global Human Recombinant LIF Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Recombinant LIF Sales by Region: 2019-2030
3.2.1 Global Human Recombinant LIF Sales by Region: 2019-2024
3.2.2 Global Human Recombinant LIF Sales by Region: 2025-2030
3.3 Global Human Recombinant LIF Revenue by Region: 2019-2030
3.3.1 Global Human Recombinant LIF Revenue by Region: 2019-2024
3.3.2 Global Human Recombinant LIF Revenue by Region: 2025-2030
3.4 North America Human Recombinant LIF Market Facts & Figures by Country
3.4.1 North America Human Recombinant LIF Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Recombinant LIF Sales by Country (2019-2030)
3.4.3 North America Human Recombinant LIF Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Recombinant LIF Market Facts & Figures by Country
3.5.1 Europe Human Recombinant LIF Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Recombinant LIF Sales by Country (2019-2030)
3.5.3 Europe Human Recombinant LIF Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Recombinant LIF Market Facts & Figures by Region
3.6.1 Asia Pacific Human Recombinant LIF Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Recombinant LIF Sales by Region (2019-2030)
3.6.3 Asia Pacific Human Recombinant LIF Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Recombinant LIF Market Facts & Figures by Country
3.7.1 Latin America Human Recombinant LIF Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Recombinant LIF Sales by Country (2019-2030)
3.7.3 Latin America Human Recombinant LIF Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Human Recombinant LIF Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Recombinant LIF Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Recombinant LIF Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Recombinant LIF Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Recombinant LIF Sales by Type (2019-2030)
4.1.1 Global Human Recombinant LIF Sales by Type (2019-2024)
4.1.2 Global Human Recombinant LIF Sales by Type (2025-2030)
4.1.3 Global Human Recombinant LIF Sales Market Share by Type (2019-2030)
4.2 Global Human Recombinant LIF Revenue by Type (2019-2030)
4.2.1 Global Human Recombinant LIF Revenue by Type (2019-2024)
4.2.2 Global Human Recombinant LIF Revenue by Type (2025-2030)
4.2.3 Global Human Recombinant LIF Revenue Market Share by Type (2019-2030)
4.3 Global Human Recombinant LIF Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Recombinant LIF Sales by Application (2019-2030)
5.1.1 Global Human Recombinant LIF Sales by Application (2019-2024)
5.1.2 Global Human Recombinant LIF Sales by Application (2025-2030)
5.1.3 Global Human Recombinant LIF Sales Market Share by Application (2019-2030)
5.2 Global Human Recombinant LIF Revenue by Application (2019-2030)
5.2.1 Global Human Recombinant LIF Revenue by Application (2019-2024)
5.2.2 Global Human Recombinant LIF Revenue by Application (2025-2030)
5.2.3 Global Human Recombinant LIF Revenue Market Share by Application (2019-2030)
5.3 Global Human Recombinant LIF Price by Application (2019-2030)
6 Key Companies Profiled
6.1 STEMCELL
6.1.1 STEMCELL Company Information
6.1.2 STEMCELL Description and Business Overview
6.1.3 STEMCELL Human Recombinant LIF Sales, Revenue and Gross Margin (2019-2024)
6.1.4 STEMCELL Human Recombinant LIF Product Portfolio
6.1.5 STEMCELL Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Human Recombinant LIF Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Human Recombinant LIF Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 YEASEN
6.3.1 YEASEN Company Information
6.3.2 YEASEN Description and Business Overview
6.3.3 YEASEN Human Recombinant LIF Sales, Revenue and Gross Margin (2019-2024)
6.3.4 YEASEN Human Recombinant LIF Product Portfolio
6.3.5 YEASEN Recent Developments/Updates
6.4 Dalian Meilun Biotech Co., Ltd.
6.4.1 Dalian Meilun Biotech Co., Ltd. Company Information
6.4.2 Dalian Meilun Biotech Co., Ltd. Description and Business Overview
6.4.3 Dalian Meilun Biotech Co., Ltd. Human Recombinant LIF Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dalian Meilun Biotech Co., Ltd. Human Recombinant LIF Product Portfolio
6.4.5 Dalian Meilun Biotech Co., Ltd. Recent Developments/Updates
6.5 R&D Systems, Inc.
6.5.1 R&D Systems, Inc. Company Information
6.5.2 R&D Systems, Inc. Description and Business Overview
6.5.3 R&D Systems, Inc. Human Recombinant LIF Sales, Revenue and Gross Margin (2019-2024)
6.5.4 R&D Systems, Inc. Human Recombinant LIF Product Portfolio
6.5.5 R&D Systems, Inc. Recent Developments/Updates
6.6 Thermo Fisher Scientific Inc.
6.6.1 Thermo Fisher Scientific Inc. Company Information
6.6.2 Thermo Fisher Scientific Inc. Description and Business Overview
6.6.3 Thermo Fisher Scientific Inc. Human Recombinant LIF Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Thermo Fisher Scientific Inc. Human Recombinant LIF Product Portfolio
6.6.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
6.7 Cell Guidance Systems LLC
6.7.1 Cell Guidance Systems LLC Company Information
6.7.2 Cell Guidance Systems LLC Description and Business Overview
6.7.3 Cell Guidance Systems LLC Human Recombinant LIF Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Cell Guidance Systems LLC Human Recombinant LIF Product Portfolio
6.7.5 Cell Guidance Systems LLC Recent Developments/Updates
6.8 Prospec-Tany Technogene Ltd.
6.8.1 Prospec-Tany Technogene Ltd. Company Information
6.8.2 Prospec-Tany Technogene Ltd. Description and Business Overview
6.8.3 Prospec-Tany Technogene Ltd. Human Recombinant LIF Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Prospec-Tany Technogene Ltd. Human Recombinant LIF Product Portfolio
6.8.5 Prospec-Tany Technogene Ltd. Recent Developments/Updates
6.9 ACROBiosystems
6.9.1 ACROBiosystems Company Information
6.9.2 ACROBiosystems Description and Business Overview
6.9.3 ACROBiosystems Human Recombinant LIF Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ACROBiosystems Human Recombinant LIF Product Portfolio
6.9.5 ACROBiosystems Recent Developments/Updates
6.10 Neuromics
6.10.1 Neuromics Company Information
6.10.2 Neuromics Description and Business Overview
6.10.3 Neuromics Human Recombinant LIF Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Neuromics Human Recombinant LIF Product Portfolio
6.10.5 Neuromics Recent Developments/Updates
6.11 BioLegend, Inc
6.11.1 BioLegend, Inc Company Information
6.11.2 BioLegend, Inc Description and Business Overview
6.11.3 BioLegend, Inc Human Recombinant LIF Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BioLegend, Inc Human Recombinant LIF Product Portfolio
6.11.5 BioLegend, Inc Recent Developments/Updates
6.12 InVitria
6.12.1 InVitria Company Information
6.12.2 InVitria Description and Business Overview
6.12.3 InVitria Human Recombinant LIF Sales, Revenue and Gross Margin (2019-2024)
6.12.4 InVitria Human Recombinant LIF Product Portfolio
6.12.5 InVitria Recent Developments/Updates
6.13 BPS Bioscience
6.13.1 BPS Bioscience Company Information
6.13.2 BPS Bioscience Description and Business Overview
6.13.3 BPS Bioscience Human Recombinant LIF Sales, Revenue and Gross Margin (2019-2024)
6.13.4 BPS Bioscience Human Recombinant LIF Product Portfolio
6.13.5 BPS Bioscience Recent Developments/Updates
6.14 ScienCell Research Laboratories, Inc
6.14.1 ScienCell Research Laboratories, Inc Company Information
6.14.2 ScienCell Research Laboratories, Inc Description and Business Overview
6.14.3 ScienCell Research Laboratories, Inc Human Recombinant LIF Sales, Revenue and Gross Margin (2019-2024)
6.14.4 ScienCell Research Laboratories, Inc Human Recombinant LIF Product Portfolio
6.14.5 ScienCell Research Laboratories, Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Recombinant LIF Industry Chain Analysis
7.2 Human Recombinant LIF Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Recombinant LIF Production Mode & Process
7.4 Human Recombinant LIF Sales and Marketing
7.4.1 Human Recombinant LIF Sales Channels
7.4.2 Human Recombinant LIF Distributors
7.5 Human Recombinant LIF Customers
8 Human Recombinant LIF Market Dynamics
8.1 Human Recombinant LIF Industry Trends
8.2 Human Recombinant LIF Market Drivers
8.3 Human Recombinant LIF Market Challenges
8.4 Human Recombinant LIF Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Lif
Dalian Meilun Biotech Co., Ltd.
STEMCELL
Merck
Yeasen
R&D Systems, Inc.
Thermo Fisher Scientific Inc
Cell Guidance Systems LLC
ProSpec-Tany TechnoGene Ltd
ACROBiosystems
Neuromics
BioLegend
InVitria
BPS Bioscience
ScienCell Research Laboratories, Inc.
List of Tables
 Table 1. Global Human Recombinant LIF Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Human Recombinant LIF Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Human Recombinant LIF Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Human Recombinant LIF Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Human Recombinant LIF Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Human Recombinant LIF Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Human Recombinant LIF Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Human Recombinant LIF Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Human Recombinant LIF, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Recombinant LIF, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Recombinant LIF, Product Type & Application
 Table 12. Global Key Manufacturers of Human Recombinant LIF, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Recombinant LIF by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Recombinant LIF as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Recombinant LIF Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Human Recombinant LIF Sales by Region (2019-2024) & (K Units)
 Table 18. Global Human Recombinant LIF Sales Market Share by Region (2019-2024)
 Table 19. Global Human Recombinant LIF Sales by Region (2025-2030) & (K Units)
 Table 20. Global Human Recombinant LIF Sales Market Share by Region (2025-2030)
 Table 21. Global Human Recombinant LIF Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Human Recombinant LIF Revenue Market Share by Region (2019-2024)
 Table 23. Global Human Recombinant LIF Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Human Recombinant LIF Revenue Market Share by Region (2025-2030)
 Table 25. North America Human Recombinant LIF Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Human Recombinant LIF Sales by Country (2019-2024) & (K Units)
 Table 27. North America Human Recombinant LIF Sales by Country (2025-2030) & (K Units)
 Table 28. North America Human Recombinant LIF Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Human Recombinant LIF Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Human Recombinant LIF Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Human Recombinant LIF Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Human Recombinant LIF Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Human Recombinant LIF Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Human Recombinant LIF Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Human Recombinant LIF Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Human Recombinant LIF Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Human Recombinant LIF Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Human Recombinant LIF Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Human Recombinant LIF Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Human Recombinant LIF Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Human Recombinant LIF Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Human Recombinant LIF Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Human Recombinant LIF Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Human Recombinant LIF Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Human Recombinant LIF Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Human Recombinant LIF Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Human Recombinant LIF Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Human Recombinant LIF Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Human Recombinant LIF Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Human Recombinant LIF Sales (K Units) by Type (2019-2024)
 Table 51. Global Human Recombinant LIF Sales (K Units) by Type (2025-2030)
 Table 52. Global Human Recombinant LIF Sales Market Share by Type (2019-2024)
 Table 53. Global Human Recombinant LIF Sales Market Share by Type (2025-2030)
 Table 54. Global Human Recombinant LIF Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Human Recombinant LIF Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Human Recombinant LIF Revenue Market Share by Type (2019-2024)
 Table 57. Global Human Recombinant LIF Revenue Market Share by Type (2025-2030)
 Table 58. Global Human Recombinant LIF Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Human Recombinant LIF Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Human Recombinant LIF Sales (K Units) by Application (2019-2024)
 Table 61. Global Human Recombinant LIF Sales (K Units) by Application (2025-2030)
 Table 62. Global Human Recombinant LIF Sales Market Share by Application (2019-2024)
 Table 63. Global Human Recombinant LIF Sales Market Share by Application (2025-2030)
 Table 64. Global Human Recombinant LIF Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Human Recombinant LIF Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Human Recombinant LIF Revenue Market Share by Application (2019-2024)
 Table 67. Global Human Recombinant LIF Revenue Market Share by Application (2025-2030)
 Table 68. Global Human Recombinant LIF Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Human Recombinant LIF Price (US$/Unit) by Application (2025-2030)
 Table 70. STEMCELL Company Information
 Table 71. STEMCELL Description and Business Overview
 Table 72. STEMCELL Human Recombinant LIF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. STEMCELL Human Recombinant LIF Product
 Table 74. STEMCELL Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Human Recombinant LIF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Merck Human Recombinant LIF Product
 Table 79. Merck Recent Developments/Updates
 Table 80. YEASEN Company Information
 Table 81. YEASEN Description and Business Overview
 Table 82. YEASEN Human Recombinant LIF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. YEASEN Human Recombinant LIF Product
 Table 84. YEASEN Recent Developments/Updates
 Table 85. Dalian Meilun Biotech Co., Ltd. Company Information
 Table 86. Dalian Meilun Biotech Co., Ltd. Description and Business Overview
 Table 87. Dalian Meilun Biotech Co., Ltd. Human Recombinant LIF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Dalian Meilun Biotech Co., Ltd. Human Recombinant LIF Product
 Table 89. Dalian Meilun Biotech Co., Ltd. Recent Developments/Updates
 Table 90. R&D Systems, Inc. Company Information
 Table 91. R&D Systems, Inc. Description and Business Overview
 Table 92. R&D Systems, Inc. Human Recombinant LIF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. R&D Systems, Inc. Human Recombinant LIF Product
 Table 94. R&D Systems, Inc. Recent Developments/Updates
 Table 95. Thermo Fisher Scientific Inc. Company Information
 Table 96. Thermo Fisher Scientific Inc. Description and Business Overview
 Table 97. Thermo Fisher Scientific Inc. Human Recombinant LIF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Thermo Fisher Scientific Inc. Human Recombinant LIF Product
 Table 99. Thermo Fisher Scientific Inc. Recent Developments/Updates
 Table 100. Cell Guidance Systems LLC Company Information
 Table 101. Cell Guidance Systems LLC Description and Business Overview
 Table 102. Cell Guidance Systems LLC Human Recombinant LIF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Cell Guidance Systems LLC Human Recombinant LIF Product
 Table 104. Cell Guidance Systems LLC Recent Developments/Updates
 Table 105. Prospec-Tany Technogene Ltd. Company Information
 Table 106. Prospec-Tany Technogene Ltd. Description and Business Overview
 Table 107. Prospec-Tany Technogene Ltd. Human Recombinant LIF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Prospec-Tany Technogene Ltd. Human Recombinant LIF Product
 Table 109. Prospec-Tany Technogene Ltd. Recent Developments/Updates
 Table 110. ACROBiosystems Company Information
 Table 111. ACROBiosystems Description and Business Overview
 Table 112. ACROBiosystems Human Recombinant LIF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. ACROBiosystems Human Recombinant LIF Product
 Table 114. ACROBiosystems Recent Developments/Updates
 Table 115. Neuromics Company Information
 Table 116. Neuromics Description and Business Overview
 Table 117. Neuromics Human Recombinant LIF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Neuromics Human Recombinant LIF Product
 Table 119. Neuromics Recent Developments/Updates
 Table 120. BioLegend, Inc Company Information
 Table 121. BioLegend, Inc Description and Business Overview
 Table 122. BioLegend, Inc Human Recombinant LIF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. BioLegend, Inc Human Recombinant LIF Product
 Table 124. BioLegend, Inc Recent Developments/Updates
 Table 125. InVitria Company Information
 Table 126. InVitria Description and Business Overview
 Table 127. InVitria Human Recombinant LIF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. InVitria Human Recombinant LIF Product
 Table 129. InVitria Recent Developments/Updates
 Table 130. BPS Bioscience Company Information
 Table 131. BPS Bioscience Description and Business Overview
 Table 132. BPS Bioscience Human Recombinant LIF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. BPS Bioscience Human Recombinant LIF Product
 Table 134. BPS Bioscience Recent Developments/Updates
 Table 135. ScienCell Research Laboratories, Inc Company Information
 Table 136. ScienCell Research Laboratories, Inc Description and Business Overview
 Table 137. ScienCell Research Laboratories, Inc Human Recombinant LIF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. ScienCell Research Laboratories, Inc Human Recombinant LIF Product
 Table 139. ScienCell Research Laboratories, Inc Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Human Recombinant LIF Distributors List
 Table 143. Human Recombinant LIF Customers List
 Table 144. Human Recombinant LIF Market Trends
 Table 145. Human Recombinant LIF Market Drivers
 Table 146. Human Recombinant LIF Market Challenges
 Table 147. Human Recombinant LIF Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Recombinant LIF
 Figure 2. Global Human Recombinant LIF Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Human Recombinant LIF Market Share by Type: 2023 & 2030
 Figure 4. Purity < 97% Product Picture
 Figure 5. Purity ≥ 97% Product Picture
 Figure 6. Global Human Recombinant LIF Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Human Recombinant LIF Market Share by Application: 2023 & 2030
 Figure 8. Laboratory
 Figure 9. University
 Figure 10. Others
 Figure 11. Global Human Recombinant LIF Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Human Recombinant LIF Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Human Recombinant LIF Sales (2019-2030) & (K Units)
 Figure 14. Global Human Recombinant LIF Average Price (US$/Unit) & (2019-2030)
 Figure 15. Human Recombinant LIF Report Years Considered
 Figure 16. Human Recombinant LIF Sales Share by Manufacturers in 2023
 Figure 17. Global Human Recombinant LIF Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Human Recombinant LIF Players: Market Share by Revenue in Human Recombinant LIF in 2023
 Figure 19. Human Recombinant LIF Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Human Recombinant LIF Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Human Recombinant LIF Sales Market Share by Country (2019-2030)
 Figure 22. North America Human Recombinant LIF Revenue Market Share by Country (2019-2030)
 Figure 23. United States Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Human Recombinant LIF Sales Market Share by Country (2019-2030)
 Figure 26. Europe Human Recombinant LIF Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Human Recombinant LIF Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Human Recombinant LIF Revenue Market Share by Region (2019-2030)
 Figure 34. China Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Human Recombinant LIF Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Human Recombinant LIF Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Human Recombinant LIF Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Human Recombinant LIF Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Human Recombinant LIF by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Human Recombinant LIF by Type (2019-2030)
 Figure 53. Global Human Recombinant LIF Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Human Recombinant LIF by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Human Recombinant LIF by Application (2019-2030)
 Figure 56. Global Human Recombinant LIF Price (US$/Unit) by Application (2019-2030)
 Figure 57. Human Recombinant LIF Value Chain
 Figure 58. Human Recombinant LIF Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Recombinant Human Leukemia Inhibitory Factor Market Research Report 2024
Global Human Leukemia Inhibitory Factor Market Research Report 2024
Global Recombinant Human Leukemia Inhibitory Factor Kit Market Research Report 2024
Global Recombinant Mouse Leukemia Inhibitory Factor Market Research Report 2024
Global Mouse Leukemia Inhibitory Factor Market Research Report 2024
Global Recombinant Mouse Leukemia Inhibitory Factor Reagent Market Research Report 2025
Global Human Leukemia Inhibitory Factor Recombinant Protein Market Research Report 2024
Leukemia Inhibitory Factor LIF Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human M CSF Protein Market Research Report 2025
Global Macrophage Colony Stimulating Factor Reagent Market Research Report 2025
Antihemophilic Factor Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Interleukin Market Insights Forecast to 2030
Global Freeze Dried Lactoferrin LF Market Research Report 2025
Global Targeted Drug for Blood Cancers Market Research Report 2024
Global Targeted Drug for Leukemia Market Research Report 2024
Global Recombinant Human Granulocyte Colony Stimulating Market Insights Forecast to 2030
Global Medical FLT3 Inhibitor Market Research Report 2024
Global Targeted Therapy Drugs for Leukemia Market Research Report 2024
Global Stem Cell Factor SCF Market Research Report 2024
Human Coagulation Factor Ⅷ Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions